US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist
  • 6.580
  • +0.110+1.70%
Close Mar 5 16:00 ET
  • 6.610
  • +0.030+0.45%
Post 18:25 ET
2.65BMarket Cap-3.89P/E (TTM)

Recursion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
33.30%58.49M
-57.54%4.51M
158.19%26.08M
30.76%14.4M
11.18%13.49M
10.57%43.88M
-22.32%10.62M
-22.61%10.1M
43.94%11.02M
128.99%12.13M
Operating revenue
33.30%58.49M
-57.54%4.51M
158.19%26.08M
30.76%14.4M
11.18%13.49M
10.57%43.88M
-22.32%10.62M
-22.61%10.1M
43.94%11.02M
128.99%12.13M
Cost of revenue
6.22%45.24M
29.48%12.79M
11.05%12.08M
-1.95%9.2M
-10.30%11.17M
-11.78%42.59M
-8.85%9.88M
-29.41%10.88M
-34.05%9.38M
59.61%12.45M
Gross profit
927.93%13.25M
-1,214.80%-8.28M
1,906.84%14M
218.54%5.21M
840.45%2.33M
115.00%1.29M
-73.80%743K
67.11%-775K
124.86%1.63M
87.44%-314K
Operating expense
40.10%492.25M
76.06%175.49M
13.75%112.36M
26.87%105.75M
41.86%98.67M
48.17%351.35M
56.18%99.67M
64.03%98.78M
39.81%83.35M
30.05%69.55M
Selling and administrative expenses
60.78%178.18M
153.42%77.19M
29.31%37.76M
12.52%31.83M
37.31%31.41M
35.81%110.82M
53.53%30.46M
49.83%29.2M
33.45%28.29M
8.54%22.87M
-General and administrative expense
60.78%178.18M
153.42%77.19M
29.31%37.76M
12.52%31.83M
37.31%31.41M
35.81%110.82M
53.53%30.46M
49.83%29.2M
33.45%28.29M
8.54%22.87M
Research and development costs
30.34%314.42M
41.52%98.33M
6.56%74.6M
34.27%73.93M
44.74%67.56M
54.93%241.23M
57.99%69.48M
71.43%70.01M
43.24%55.06M
43.88%46.68M
Other operating expenses
49.79%-351K
86.89%-35K
----
-1,200.00%-13K
---303K
-331.48%-699K
---267K
-302.80%-431K
95.24%-1K
----
Operating profit
-36.83%-479M
-85.76%-183.77M
1.20%-98.35M
-23.04%-100.54M
-37.89%-96.34M
-42.46%-350.06M
-62.23%-98.93M
-59.09%-99.55M
-23.45%-81.72M
-24.80%-69.87M
Net non-operating interest income expense
-25.41%14.19M
-10.70%4.02M
-33.91%3.27M
-41.76%2.87M
-13.21%4.03M
206.81%19.02M
22.54%4.5M
172.09%4.95M
672.88%4.93M
6,257.53%4.64M
Non-operating interest income
-17.57%15.76M
2.17%4.62M
-23.13%3.83M
-34.11%3.27M
-13.13%4.05M
205.66%19.12M
22.81%4.52M
171.52%4.98M
660.28%4.96M
5,256.32%4.66M
Non-operating interest expense
1,520.62%1.57M
2,226.92%605K
2,112.00%553K
1,415.38%394K
5.26%20K
76.36%97K
100.00%26K
92.31%25K
85.71%26K
35.71%19K
Other net income (expense)
102.76%30K
132.55%854K
-137.57%-594K
-787.72%-392K
255.34%160K
-2,190.38%-1.09M
-1,365.92%-2.62M
413.31%1.58M
914.29%57K
-45.07%-103K
Other non- operating income (expenses)
102.76%30K
132.55%854K
-137.57%-594K
-787.72%-392K
255.34%160K
-2,190.38%-1.09M
-1,365.92%-2.62M
413.31%1.58M
914.29%57K
-45.07%-103K
Income before tax
-39.94%-464.79M
-84.32%-178.9M
-2.86%-95.68M
-27.81%-98.06M
-41.06%-92.15M
-38.69%-332.13M
-68.82%-97.06M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
Income tax
72.26%-1.13M
100.17%7K
167K
-523K
-779K
-4.06M
-4.06M
0
0
0
Net income
-41.33%-463.66M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
-36.99%-328.07M
-61.75%-93M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
Net income continuous Operations
-41.33%-463.66M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
-36.99%-328.07M
-61.75%-93M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
Minority interest income
Net income attributable to the parent company
-41.33%-463.66M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
-36.99%-328.07M
-61.75%-93M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-41.33%-463.66M
-92.38%-178.91M
-3.04%-95.84M
-27.13%-97.54M
-39.87%-91.37M
-36.99%-328.07M
-61.75%-93M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
Basic earnings per share
-6.96%-1.69
-26.19%-0.53
20.93%-0.34
-5.26%-0.4
-14.71%-0.39
-16.18%-1.58
-35.48%-0.42
-22.86%-0.43
0.00%-0.38
-3.03%-0.34
Diluted earnings per share
-6.96%-1.69
-26.19%-0.53
20.93%-0.34
-5.26%-0.4
-14.71%-0.39
-16.18%-1.58
-35.48%-0.42
-22.86%-0.43
0.00%-0.38
-3.03%-0.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 33.30%58.49M-57.54%4.51M158.19%26.08M30.76%14.4M11.18%13.49M10.57%43.88M-22.32%10.62M-22.61%10.1M43.94%11.02M128.99%12.13M
Operating revenue 33.30%58.49M-57.54%4.51M158.19%26.08M30.76%14.4M11.18%13.49M10.57%43.88M-22.32%10.62M-22.61%10.1M43.94%11.02M128.99%12.13M
Cost of revenue 6.22%45.24M29.48%12.79M11.05%12.08M-1.95%9.2M-10.30%11.17M-11.78%42.59M-8.85%9.88M-29.41%10.88M-34.05%9.38M59.61%12.45M
Gross profit 927.93%13.25M-1,214.80%-8.28M1,906.84%14M218.54%5.21M840.45%2.33M115.00%1.29M-73.80%743K67.11%-775K124.86%1.63M87.44%-314K
Operating expense 40.10%492.25M76.06%175.49M13.75%112.36M26.87%105.75M41.86%98.67M48.17%351.35M56.18%99.67M64.03%98.78M39.81%83.35M30.05%69.55M
Selling and administrative expenses 60.78%178.18M153.42%77.19M29.31%37.76M12.52%31.83M37.31%31.41M35.81%110.82M53.53%30.46M49.83%29.2M33.45%28.29M8.54%22.87M
-General and administrative expense 60.78%178.18M153.42%77.19M29.31%37.76M12.52%31.83M37.31%31.41M35.81%110.82M53.53%30.46M49.83%29.2M33.45%28.29M8.54%22.87M
Research and development costs 30.34%314.42M41.52%98.33M6.56%74.6M34.27%73.93M44.74%67.56M54.93%241.23M57.99%69.48M71.43%70.01M43.24%55.06M43.88%46.68M
Other operating expenses 49.79%-351K86.89%-35K-----1,200.00%-13K---303K-331.48%-699K---267K-302.80%-431K95.24%-1K----
Operating profit -36.83%-479M-85.76%-183.77M1.20%-98.35M-23.04%-100.54M-37.89%-96.34M-42.46%-350.06M-62.23%-98.93M-59.09%-99.55M-23.45%-81.72M-24.80%-69.87M
Net non-operating interest income expense -25.41%14.19M-10.70%4.02M-33.91%3.27M-41.76%2.87M-13.21%4.03M206.81%19.02M22.54%4.5M172.09%4.95M672.88%4.93M6,257.53%4.64M
Non-operating interest income -17.57%15.76M2.17%4.62M-23.13%3.83M-34.11%3.27M-13.13%4.05M205.66%19.12M22.81%4.52M171.52%4.98M660.28%4.96M5,256.32%4.66M
Non-operating interest expense 1,520.62%1.57M2,226.92%605K2,112.00%553K1,415.38%394K5.26%20K76.36%97K100.00%26K92.31%25K85.71%26K35.71%19K
Other net income (expense) 102.76%30K132.55%854K-137.57%-594K-787.72%-392K255.34%160K-2,190.38%-1.09M-1,365.92%-2.62M413.31%1.58M914.29%57K-45.07%-103K
Other non- operating income (expenses) 102.76%30K132.55%854K-137.57%-594K-787.72%-392K255.34%160K-2,190.38%-1.09M-1,365.92%-2.62M413.31%1.58M914.29%57K-45.07%-103K
Income before tax -39.94%-464.79M-84.32%-178.9M-2.86%-95.68M-27.81%-98.06M-41.06%-92.15M-38.69%-332.13M-68.82%-97.06M-53.89%-93.02M-17.03%-76.73M-16.70%-65.33M
Income tax 72.26%-1.13M100.17%7K167K-523K-779K-4.06M-4.06M000
Net income -41.33%-463.66M-92.38%-178.91M-3.04%-95.84M-27.13%-97.54M-39.87%-91.37M-36.99%-328.07M-61.75%-93M-53.89%-93.02M-17.03%-76.73M-16.70%-65.33M
Net income continuous Operations -41.33%-463.66M-92.38%-178.91M-3.04%-95.84M-27.13%-97.54M-39.87%-91.37M-36.99%-328.07M-61.75%-93M-53.89%-93.02M-17.03%-76.73M-16.70%-65.33M
Minority interest income
Net income attributable to the parent company -41.33%-463.66M-92.38%-178.91M-3.04%-95.84M-27.13%-97.54M-39.87%-91.37M-36.99%-328.07M-61.75%-93M-53.89%-93.02M-17.03%-76.73M-16.70%-65.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -41.33%-463.66M-92.38%-178.91M-3.04%-95.84M-27.13%-97.54M-39.87%-91.37M-36.99%-328.07M-61.75%-93M-53.89%-93.02M-17.03%-76.73M-16.70%-65.33M
Basic earnings per share -6.96%-1.69-26.19%-0.5320.93%-0.34-5.26%-0.4-14.71%-0.39-16.18%-1.58-35.48%-0.42-22.86%-0.430.00%-0.38-3.03%-0.34
Diluted earnings per share -6.96%-1.69-26.19%-0.5320.93%-0.34-5.26%-0.4-14.71%-0.39-16.18%-1.58-35.48%-0.42-22.86%-0.430.00%-0.38-3.03%-0.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Donald Trump Donald Trump

Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.

No. Symbol % Year-to-date
Eli Lilly and Co
LLY
+20.64%
Nucor
NUE
+13.52%
Steel Dynamics
STLD
+11.97%
4
Deere
DE
+10.34%
5
Strategy
MSTR
+6.54%
Log In for the Full List
Unlock Now
Headlines
Stock market closing | As the tariff tensions ease, the three major Indexes rebounded by over 1%; China Concept Stocks rose across the board, with Alibaba increasing by over 8%.
7 mins ago
With tariff impacts and non-farm payrolls coming, the S&P 500 Index may experience significant volatility!
Mar 5 21:00
Top 20 by transaction amount | Palantir rose nearly 7%, receiving favorable outlook from Institutions; MSTR increased over 12%, accumulating nearly 23% growth over two days.
3 mins ago
A price war for weight loss drugs is underway! Novo-Nordisk A/S has entered the direct sales battlefield, and the price of Wegovy has plummeted.
5 mins ago
The three major auto companies banded together to request that Trump delay the tariffs on the Autos industry with Mexico for one month.
15 mins ago